ZENOBIA THERAPEUTICS, INC

SBIR PHASE II: A WEB-APPLICATION THAT ENABLES HANDS-ON BIOTECH LABORATORY EDUCATION FOR STUDENTS REGARDLESS OF SOCIOECONOMIC STATUS -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT IS EQUITABLE ACCESS TO A QUALITY SCIENCE EDUCATION REGARDLESS OF SOCIOECONOMIC S

ZENOBIA THERAPEUTICS, INC is a company in national science foundation based in San Diego, California, US.

Profile

SBIR PHASE II: A WEB-APPLICATION THAT ENABLES HANDS-ON BIOTECH LABORATORY EDUCATION FOR STUDENTS REGARDLESS OF SOCIOECONOMIC STATUS -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT IS EQUITABLE ACCESS TO A QUALITY SCIENCE EDUCATION REGARDLESS OF SOCIOECONOMIC STATUS OR GEOGRAPHIC LOCATION. ACROSS THE NATION, SCIENCE ILLITERACY IS AN ONGOING ISSUE WITH ONLY 30% OF STUDENTS TESTING AS HAVING A BASIC KNOWLEDGE OF SCIENCE. AS A RESULT, THE U.S. DOES NOT HAVE ENOUGH TRAINED SCIENTISTS TO COMMERCIAL OR ACADEMIC LABORATORIES. THIS SITUATION HAS BEEN DEEMED A NATIONAL CRISIS AND IS CONSIDERED A RISK TO U.S. NATIONAL SECURITY. A QUALITY SCIENCE EDUCATION HAS LASTING BENEFITS TO STUDENTS INCLUDING MORE PERSUASIVE AND CLEAR COMMUNICATION SKILLS, AND THE ABILITY TO DESIGN AND DEVELOP CRITICAL APPROACHES TO PROBLEM-SOLVING. THE LONG-TERM GOAL OF THIS PROGRAM IS TO RAISE SCIENCE LITERACY ACROSS THE NATION AND PROVIDE CAREER READINESS TRAINING FOR THE NEXT GENERATION OF SCIENTISTS. THE PROGRAM MEETS ALL THREE DIMENSIONS OF NEXT GENERATION SCIENCE STANDARDS. A BOOK VERSION OF THE PROGRAM IS BEING ROLLED-OUT TO INDEPENDENT STUDY CHARTER SCHOOLS IN CALIFORNIA. THE ONLINE PROGRAM WILL BE TESTED IN SCHOOLS WHICH HAVE ADOPTED THE BOOKS. BOTH BOOK AND ONLINE VERSIONS WILL BE EXPANDED TO CHARTER SCHOOLS, PRIVATE SCHOOLS, AND EVENTUALLY PUBLIC

As a business in national science foundation, ZENOBIA THERAPEUTICS, INC is listed here with the public details available about it.

Its base of operations is San Diego, California, US.

Directory data places it at the Phase II stage.

Its team size is recorded as 1-10 employees.

Public records show total funding of about $1M.

Website: zenobia-therapeutics.com